| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/05/1992 | EP0497368A1 CNP analog peptides and their use |
| 08/05/1992 | EP0497366A2 Antimicrobial peptides and their use against plant pathogens |
| 08/05/1992 | EP0497353A2 Oral antibacterial compositions and method for the improvement of gastrointestinal absorption of penem or carbapenem antibiotics |
| 08/05/1992 | EP0497341A2 Synergistic composition comprising a fibroblast growth factor and a sulfated polysaccahride, for use as antiviral agent |
| 08/05/1992 | EP0497275A2 Generation of CD4+ helper T cells with interleukin 2 and interleukin 4 from L-phenylalanine methyl ester treated human peripheral blood cells |
| 08/05/1992 | EP0497274A2 Generation of adherent LAK cells with interleukin-2 and interleukin-4 |
| 08/05/1992 | EP0497085A1 Heterocyclic ketone prostaglandin analogs |
| 08/05/1992 | EP0497001A2 Oxidized-type glutathione alkyl ester |
| 08/05/1992 | EP0496973A2 Somatotropins with alterations in the alpha-helix 1 region, and combinations with other mutations |
| 08/05/1992 | EP0496833A1 BIOSYNTHETIC CONSTRUCTS OF TGF-$g(b) |
| 08/05/1992 | EP0496818A1 MONOCLONAL ANTIBODY SPECIFIC FOR IgA RECEPTOR |
| 08/05/1992 | EP0496806A1 Materials and methods for the treatment of foreign tissue |
| 08/05/1992 | CN1063308A Use of interleukin-10 in adoptive immunotherapy of cancer |
| 08/05/1992 | CN1063227A Use of il-4 to enhance immune response to immunogens in vaccines |
| 08/05/1992 | CA2101331A1 Factor iia inhibitors |
| 08/04/1992 | US5136076 Splitting of racemic 3-acetylthio-2-benzyl propionic acid by reaction with ephedrin, separation of salts, freeing of the acid and coupling with the corresponding amino acid ester |
| 08/04/1992 | US5136023 Genetically engineered; activity of human fibronectin |
| 08/04/1992 | US5136021 TNF-inhibitory protein and a method of production |
| 08/04/1992 | US5135956 Fatty alcohol |
| 08/04/1992 | US5135952 Antiinflammatory and/or antiallergic methods |
| 08/04/1992 | US5135939 Treating thermobotic and vasospastic disease |
| 08/04/1992 | US5135934 3-phenyl-5,6-dihydrobenz(c) acridine-7-carboxylic acids and related compounds as immunosuppressive agents |
| 08/04/1992 | US5135919 Method and a pharmaceutical composition for the inhibition of angiogenesis |
| 08/04/1992 | US5135916 Inhibition of complement mediated inflammatory response |
| 08/04/1992 | US5135913 Increasing subcutaneous fat by administering copper-peptide complex |
| 08/04/1992 | US5135912 Natriuretic peptides from the pituitary prohormone proopiomelanocortin |
| 08/04/1992 | US5135910 Nisin compositions for use as enhanced, broad range bactericides |
| 08/04/1992 | US5135856 Culturing African green monkey epithelial cells in low sodium medium |
| 08/04/1992 | CA1305932C Process for the preparation of human antithrombin iii (atiii), vectors and host cells suitable for this purpose, biologically active atiii obtained in this way and medicaments containing the latter |
| 08/04/1992 | CA1305928C Monoclonal antibody specific to a novel epitope of the lfa-1 antigen of human t lymphocytes |
| 08/02/1992 | WO1992013569A1 Targeted polymeric conjugates of cyclosporin and method for their preparation |
| 08/02/1992 | CA2079590A1 Targeted polymeric conjugates of cyclosporin and method for their preparation |
| 08/01/1992 | WO1992013886A1 Composition of antibodies directed against the humain or animal interleukin-2 receiver |
| 08/01/1992 | WO1992013545A1 Endothelin converting enzyme inhibitors |
| 08/01/1992 | CA2100171A1 Endothelin converting enzyme inhibitors |
| 08/01/1992 | CA2078450A1 Composition of antibodies directed against the human or animal interleukin-2 receiver |
| 08/01/1992 | CA2060278A1 Enhanced generation of adherent lymphokine-activated killer cells with interleukin-2 and interleukin-4 from l-phenylalanine methyl ester-treated human peripheral blood cells |
| 08/01/1992 | CA2060277A1 Synergistic composition comprising a fibroblast growth factor and a sulfated polysaccharide, for use as antiviral agent |
| 08/01/1992 | CA2060270A1 Generation of cd4 helper t cells with interleukin 2 and interleukin 4 from l-phenylalanine methyl ester treated human peripheral blood cells |
| 07/31/1992 | WO1992013557A1 Stabilized antibody fragments |
| 07/31/1992 | CA2098097A1 Stabilized antibody fragments |
| 07/30/1992 | WO1992012636A1 Derivatives of porphycene of direct utility in photodynamic therapy or as intermediates for synthesis of photoactivatable dyes suitable for photodynamic therapy |
| 07/30/1992 | CA2101780A1 Derivatives of porphycene of direct utility in photodynamic therapy or as intermediates for synthesis of photoactivatable dyes suitable for photodynamic therapy |
| 07/29/1992 | WO1992012728A1 Repressors of the trans-activating function of papillomavirus e2 proteins |
| 07/29/1992 | EP0496725A2 Complex containing coagulation factor IX |
| 07/29/1992 | EP0496606A1 Vav proto-oncogene protein |
| 07/29/1992 | EP0496452A1 Novel endothelin receptor antagonists isolated from microbispora |
| 07/29/1992 | EP0496378A1 Biphenylderivatives, drugs containing these compounds and processes for their preparation |
| 07/29/1992 | EP0496327A1 Polypeptides with prourokinase activity, plasmids coding therefor and process for their preparation and use |
| 07/29/1992 | EP0496162A2 Peptide inhibitors of RAS-GAP interaction |
| 07/29/1992 | EP0496013A1 Synthetic peptide derived from human lipocortin V and use thereof |
| 07/29/1992 | EP0495995A1 Plasmid for use in producing inflamed region derived phospholipase a 2? inhibitory protein, microbial cell, and production and use of said protein |
| 07/29/1992 | EP0495963A1 Improved hypoglycemics |
| 07/29/1992 | EP0495893A1 Dopamine releasing protein |
| 07/29/1992 | EP0495822A1 Carboxyalkyl dipeptide inhibitors of endopeptidases |
| 07/29/1992 | EP0435996A4 Modified transforming growth factor -g(a) oligopeptides and pharmaceutical compositions thereof |
| 07/29/1992 | EP0396555B1 Purification of monomeric interferon |
| 07/29/1992 | EP0346501B1 Pharmaceutical preparation for treating immunodeficiency conditions |
| 07/29/1992 | EP0313643B1 Methods and compositions for preventing ulcers |
| 07/29/1992 | EP0268678B1 Novel 5-fluorouridine compounds and process for their preparation |
| 07/29/1992 | CN1063110A Amedes of antibiotic ge 2270 factors |
| 07/29/1992 | CN1063108A Trifluoromethylktone derivatives and processes for preparation thereof and use thereof |
| 07/29/1992 | CN1017626B Growth resulating factor for new cell |
| 07/29/1992 | CA2057546A1 Heterocyclic ketone prostaglandin analogs |
| 07/28/1992 | US5134227 DNA encoding immunoreactive, chimeric HTLV-III GAG proteins |
| 07/28/1992 | US5134225 Processes and intermediates for N-(S-3-alkyl-heptanoyl)-D-gamma-glutamyl-D-alanine |
| 07/28/1992 | US5134130 Lipid emulsion for treating aids |
| 07/28/1992 | US5134125 Glutamyl glutamine |
| 07/28/1992 | US5134124 Glaucoma |
| 07/28/1992 | US5134123 Amino acid derivatives |
| 07/28/1992 | US5134122 Salts of peptides, sustained release |
| 07/28/1992 | US5134121 Nerve growth factor peptides |
| 07/28/1992 | US5134120 Use of growth hormone to enhance porcine weight gain |
| 07/28/1992 | US5134119 Treatment of inflammation using 358 substituted alpha-antitrypsin |
| 07/28/1992 | US5134076 Monoclonal antibodies specific for protease nexin-1 and puriciation of protease nexin-1 using monoclonal antibodies |
| 07/28/1992 | US5134075 Antitumor agents |
| 07/28/1992 | US5133963 Method of producing commercially useful poultry products with increased concentrations of Omega-3 polyunsaturated fatty acids |
| 07/28/1992 | US5133962 Method of controlling coleopteran insects with Bacillus thuringiensis |
| 07/28/1992 | US5133960 Use of tnf and lt for the preparation of drugs |
| 07/28/1992 | US5133956 Radiolabeled metal-binding protein for the treatment of arthritis |
| 07/28/1992 | CA1305829C Ovine inhibin |
| 07/28/1992 | CA1305827C Spergualin-related compounds and process for producing the same |
| 07/28/1992 | CA1305678C Recombinant dna clone encoding laminin receptor |
| 07/26/1992 | WO1992012727A1 Laminin a chain domain vi polypeptides |
| 07/26/1992 | CA2101052A1 Laminin a chain domain vi polypeptides |
| 07/26/1992 | CA2057547A1 Vav proto-oncogene protein |
| 07/25/1992 | WO1992012729A1 Monoclonal antibodies to elam-1 and their uses |
| 07/25/1992 | CA2100681A1 Monoclonal antibodies to elam-1 and their uses |
| 07/25/1992 | CA2059857A1 Biphenyl derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 07/25/1992 | CA2059380A1 Endothelin receptor antagonists isolated from microbispora |
| 07/23/1992 | WO1992012999A1 Novel insulin analogs |
| 07/23/1992 | WO1992012721A1 Amylase-electrolyte oral rehydration method and apparatus |
| 07/23/1992 | WO1992012245A1 Human bfgf derivatives, their analogs and process for their production |
| 07/23/1992 | WO1992012244A1 Genes which code for guinea pig and human platelet activating factor receptors |
| 07/23/1992 | WO1992012242A1 Modified hepatocytes and uses therefor |
| 07/23/1992 | WO1992012176A1 Cytokine-induced protein, tsg-14, dna coding therefor and uses thereof |
| 07/23/1992 | WO1992012172A1 Amides of antibiotic ge 2270 factors |
| 07/23/1992 | WO1992012170A1 Inhibitions of endothelin formation |
| 07/23/1992 | WO1992011896A1 Drug delivery system |
| 07/23/1992 | WO1992011869A1 Non-depleting cd4-specific monoclonal antibodies for the treatment of insulin-dependent diabetes mellitus (iddm) |